Banner Image

prescription-drug-news-regulations-employers

New Oral Diabetes Drug May Replace Injectables

Sep 20, 2019 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers
Novo Nordisk’s Rybelsus was FDA approved today and it is expected to stir up the diabetes market. This is the first oral tablet formulation of semaglutide, which may be better known to you as Ozempic from all the TV commercials with the catchy jingle.
Read more ▸▸

HHS Proposes Action Plan to Import Foreign Prescription Drugs

Aug 30, 2019 | Trends, Insights & Analysis, News, Prescription Drug News & Regulations - Employers
The US Department of Health and Human Services (HHS) has announced a plan to lower drug costs by importing prescription drugs intended for sale in foreign markets.
Read more ▸▸

A Busy Month in Washington - Drug News of Note July 2019

Jul 30, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest drug news, FDA approvals, and regulations. This month, we highlight the Senate's proposal for an inflation-based drug pricing cap, HHS withdrawing its proposal to eliminate rebates for Part D and Medicaid managed care, and HHS' proposed rule for WAC disclosure on advertising hits a snag.
Read more ▸▸

What we learned from the Amazon PillPack and CVS Caremark Lawsuit - Drug News of Note June 2019

Jun 27, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest drug news, FDA approvals, and regulations. This month, we highlight the CVS Caremark / PillPack non compete, the international pricing index, and the FDA's new opioid approval process.
Read more ▸▸

HHS Requires List Price to Be Included in TV Drug Advertisements - Drug News of Note May 2019

May 31, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we highlight HHS requirement that list price be included in TV ads, FDA approval of Zolgensma, and Gilead Sciences agreement to donate PrEP medications to a government effort to reduce HIV rates.
Read more ▸▸

Prescription Drug News of Note - April 2019

May 1, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we highlight CMS' targeting of manufacturer coupons, Sanofi's launching of a flat fee program for insulins, and Amazon's initial marketing of PillPack to Amazon Prime members
Read more ▸▸

Prescription Drug News of Note - March 2019

Mar 29, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we highlight news of Louisiana's new Hepatitis C cost containment program, Eli Lilly's new authorized generic insulin, and the FDA's approval of a new Diovan generic.
Read more ▸▸

Prescription Drug News of Note - February 2019

Feb 28, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations. This month, we have an update on the NASH pipeline, notify on a black box warning for Uloric, a gout medication, and an update on HHS blocking drug rebates for government sponsored plans
Read more ▸▸

Anthem to Transition Members to IngenioRx PBM 10 Months Sooner Than Expected

Feb 6, 2019 | Trends, Insights & Analysis, Drug Pricing, Prescription Drug News & Regulations - Employers, Pharmacy Benefit Managers
Expectations were for the new PBM to launch in 2020, but Anthem recently announced that they are accelerating the launch of IngenioRx and expect to begin transitioning members by the second quarter of 2019. This transition is starting 10 months sooner than the industry expected.
Read more ▸▸

HHS Proposes Rule to Change Anti Kickback Laws

Feb 5, 2019 | Trends, Insights & Analysis, Drug Pricing, Prescription Drug News & Regulations - Employers, Pharmacy Benefit Managers
On January 31st, the Department of Health and Human Services (HHS) proposed major changes to the federal Anti-Kickback Statute that If passed, will bring a new level of transparency to PBM contracting.
Read more ▸▸

Prescription Drug News of Note - January 2019

Jan 31, 2019 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Updated Management Guidelines for AFib | Cancer Rates Continue to Fall | Increased Spending Within Type 1 Diabetes
Read more ▸▸

Prescription Drug News of Note - December 2018

Dec 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Oncology biosimilars approved by FDA | Guidance on NASH medication development | January price increases
Read more ▸▸

Prescription Drug News of Note - November 2018

Nov 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Generic for MS | New recommendations on HIV therapy | FDA approves new cancer medication with a unique indication
Read more ▸▸

Prescription Drug News of Note - October 2018

Oct 30, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Cholesterol drug price reduction?! New FDA approval on a flu treatment | Comparative results of two MS products | FDA expands indication for Hemophilia medication
Read more ▸▸

Prescription Drug News of Note - September 2018

Oct 1, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes figures on the prevalence of Diabetes among US adults, new Migraine management products, Vascepa showing reduction in cardiovascular events, and new Hepatitis C generics,.
Read more ▸▸

Prescription Drug News of Note - August 2018

Aug 29, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of a first-of-its-kind peripheral nerve disease (polyneuropathy) therapy, and the latest on Teva's EpiPen generic
Read more ▸▸

Prescription Drug News of Note - July 2018

Jul 31, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of Tibsovo and Nivestym, and highlights positive results from an Alzheimer's trial
Read more ▸▸

Prescription Drug News of Note - June 2018

Jun 29, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of marijuana-based seizure medication, thoughts on whether OLUMIANT change inflammatory drug pricing, an analysis of Part D spending on brand drugs, and last but not least, Amazon's acquisition of PillPack.
Read more ▸▸

Prescription Drug News of Note - May 2018

May 31, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - April 2018

Apr 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Making Sense of Benefit M&A

Mar 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Pharmacy Benefit Managers
With recent mergers like the Cigna/Express Scripts (ESI) deal, stakeholders across the pharmaceutical industry are curious about the future of independent PBMs, the future of pharmacy carve-out, the opportunity for Truveris, and if/how Amazon can be a catalyst to a major change in the way that we experience, and pay for, healthcare.
Read more ▸▸

Prescription Drug News of Note - March 2018

Mar 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - February 2018

Feb 27, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approvals, Prescription spending trends, and the latest on Albertson's and Rite Aid
Read more ▸▸

Prescription Drug News of Note - January 2018

Jan 26, 2018 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approves 46 Novel Medications in 2017, Hospitals to Start Their Own Generic Drug Company
Read more ▸▸

Prescription Drug News of Note - November 2017

Nov 28, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

Prescription Drug News of Note - October 2017

Oct 15, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Prescription Drug News of Note - September 2017

Sep 11, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Prescription Drug News of Note – August 2017

Aug 1, 2017 | Trends, Insights & Analysis, Enterprise Employers, Labor Unions, State & Public Employers, Brokers, Prescription Drug News & Regulations - Employers
A rundown of the latest FDA approvals and regulations from August 2017, with an expert take on what you need to know in the prescription drug industry.
Read more ▸▸

10 Questions Employers Should Be Asking About the Cadillac Tax

Apr 20, 2016 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
The Cadillac Tax is an excise tax levied on employers that provide high-cost health benefit plans to their employees.
Read more ▸▸